Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Cortical Lesions Form Predominantly in Early Multiple Sclerosis.
Oligodendrocyte lineage cell-specific GPR17/Gelsolin signaling regulates remyelination and cognitive recovery after subarachnoid hemorrhage.
MOG-IgG Positivity Does Not Equal MOGAD: Diagnostic Pitfall and Misapplication of the International MOGAD Panel Proposed Criteria in Real-World Practice.
Essential elements for guiding patient segmentation in precision pharmacotherapy for rheumatoid arthritis: lessons up to 2025.
Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
From MRI activity to treatment escalation in relapsing multiple sclerosis: what can new T2 lesions tell us?
Loss of disrupts myelination in a zebrafish model of -associated disease.
Effects of strength and balance training on the structure of the aging brain.
Reactive stepping strategies after lateral perturbations in people with multiple sclerosis.
Oligodendrocyte dysfunction in neurodegenerative diseases: pathological features, underlying mechanisms and therapeutic targeting.
EXPRESS: Metabolic reprogramming of oligodendrocyte lineage cells in ischemic stroke: insights from literature review and single-cell transcriptomic re-analyses.
Protein-enhanced small molecule disruptors of ordered membrane domains.
Accelerated Deep-Learning-Based Image Reconstruction for 3D T2 Dark-Fluid in Imaging of Multiple Sclerosis.
Lifetime exposure to shift work and risk of multiple sclerosis: retrospective and prospective cohort studies in UK Biobank.
Diagnostic dilemma in visual loss due to diabetic papillopathy masquerading as optic neuritis.
Therapeutic Potential of Mesenchymal Stem Cells in Multiple Sclerosis: An Updated Review.
Itolizumab targets the CD6-ALCAM axis to limit T-cell responses and brain barrier diapedesis in multiple sclerosis.
Hippocampal teneurin-4 knockdown promotes depression-like behavioral phenotypes by disrupting oligodendrocyte differentiation in mice.
Diagnostic yield of the 2022 optic neuritis criteria and an antibody-stratified adjunct in an antibody-predominant Chinese clinical sample.
[Prospects for retroelement-targeted therapy of schizophrenia].
Video Head Impulse Testing in Relapsing Remitting Multiple Sclerosis: Evaluation of Canal Gains, Asymmetry, and Corrective Saccades with Cerebellar Lesions.
Editors' Note: Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European Cohort.
Dynamic metabolic programming of monocyte-derived cells defines immunity in CNS disease.
Toll-like receptor 4 mediates lipopolysaccharide-induced emesis.
Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis: Mechanistic Considerations Across Relapsing and Progressive Disease.

Pages